Fosbretabulin

DB12577InvestigationalSmall molecule

Fosbretabulin has been investigated for the treatment of Anaplastic Thyroid Cancer.

Chemical structure of Fosbretabulin
Mechanism
Curator reviewed
Formula / weight
C18H21O8P · 396.332 g/mol (avg)
Also known as
2-METHOXY-5-((Z)-2-(3,4,5-TRIMETHOXYPHENYL)VINYL)PHENYL DIHYDROGEN PHOSPHATE · CA4P · PHENOL, 2-METHOXY-5-((1Z)-2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-,1-(DIHYDROGEN PHOSPHATE) · PHENOL, 2-METHOXY-5-((Z)-2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-, DIHYDROGEN PHOSPHATE · Phosbretabulin

Resolves to

Compound
UNIII5590ES2QZCAS222030-63-9ChEMBLCHEMBL1206232PubChem5351387
Structure
InChIKeyWDOGQTQEKVLZIJ-WAYWQWQTSA-NSMILESCOC1=CC=C(\C=C/C2=CC(OC)=C(OC)C(OC)=C2)C=C1OP(O)(O)=O
Targets
P07437TUBB

What you can answer from here — as of September 16, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
16Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fosbretabulin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In